MedPath

The survey of the effect of Billy Cuttermana on decreasing jaundice in neonates

Phase 3
Conditions
eonatal Jaundice.
Neonatal Jaundice, Unspecified
Registration Number
IRCT2015120425203N2
Lead Sponsor
Dezful University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
350
Inclusion Criteria

Healthy term breast-fed infants weighing 2.5 to 4 Kg after 36 hours until 14 days developed jaundice and photo therapy indicated.

Exclusion criteria: per-and post term infants; formula feeding; the presence of any malformations and associated diseases such as sepsis; weighing less than 2.5 and more than 4 kg; neonates developed jaundice after 14 days who need Intensive photo therapy or exchange; ABO or RH incompatibility; presence direct hyper bilirubinemia.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bilirubin. Timepoint: On arrival at the hospital, 12, 24, 48, 72 hours after it. Method of measurement: Bailey Test milligrams per deciliter.
Secondary Outcome Measures
NameTimeMethod
Bilirubin. Timepoint: 12, 24, 48, 72 hours after it. Method of measurement: Bailey Test milligrams per deciliter.
© Copyright 2025. All Rights Reserved by MedPath